Insulinoma diagnostic criteria: Difference between revisions
Line 35: | Line 35: | ||
{{familytree/start}}< | {{familytree/start}}<Algorithm used commonly in the past>{{familytree | | | | | | | | | | | A01 | | | | | |A01=Suspicion of Insulinoma}} | ||
{{familytree | | | | | | | | | | | |!| | | | | | | | }} | {{familytree | | | | | | | | | | | |!| | | | | | | | }} | ||
{{familytree | | | | | | | | | | | B01 | | | | | |B01=Whipple's triad confirmed}} | {{familytree | | | | | | | | | | | B01 | | | | | |B01=Whipple's triad confirmed}} | ||
Line 43: | Line 43: | ||
{{familytree | | | | | | D01 | | | | | | | | | | |D02|D01= Positive|D02=Negative}} | {{familytree | | | | | | D01 | | | | | | | | | | |D02|D01= Positive|D02=Negative}} | ||
{{familytree | | | | | | |!| | | | | | | | | | | | |!| }} | {{familytree | | | | | | |!| | | | | | | | | | | | |!| }} | ||
{{familytree | | | | | | E01 | {{familytree | | | | | | E01 | | | | | | | | | | |E02 |E01=MRI/CT|E02= Prolonged OGTT or mixed meal}} | ||
{{familytree | | |,|-|-|-|+ | {{familytree | | |,|-|-|-|+|-|-|-|.| | | | |,|-|-|^|-|-|.|}} | ||
{{familytree | | F01 | | |F02 | {{familytree | | F01 | | |F02| |F03| | | | |F04| | | | | | |F05|F01=No visible lesion|F02=Visible<br>lesion(s)|F03=Unresectable<br>liver metastasis|F04=Nohypoglycemia| F05= Hypoglycemia}} | ||
{{familytree | | | | | | | | | | | | |!| | | |!| | | | |!| | }} | {{familytree | | | | | | | | | | | | |!| | | |!| | | | |!| | }} | ||
{{familytree | | | | | | | | | | | | F01 | | F02 | | | F03 |F01=F01|F02=F02|F03=F03}} | {{familytree | | | | | | | | | | | | F01 | | F02 | | | F03 |F01=F01|F02=F02|F03=F03}} |
Revision as of 16:39, 18 August 2017
Insulinoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Insulinoma diagnostic criteria On the Web |
American Roentgen Ray Society Images of Insulinoma diagnostic criteria |
Risk calculators and risk factors for Insulinoma diagnostic criteria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]
Overview
The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met: [criterion 1], [criterion 2], [criterion 3], and [criterion 4].
OR
The diagnosis of [disease name] is based on the [criteria name] criteria, which include [criterion 1], [criterion 2], and [criterion 3].
OR
The diagnosis of [disease name] is based on the [definition name] definition, which includes [criterion 1], [criterion 2], and [criterion 3].
OR
There are no established criteria for the diagnosis of [disease name].
Diagnostic Criteria
- The classical diagnosis of insulinoma is based on the Whipple's triad(1935)[1], which includes:
- Hypoglycemia( fasting blood glucose <50 mg/dL)
- Symptoms of hypoglycemia[2][3]
- Neuroglycopenic- visual disturbances(blurring of vision, diplopia), confusion, weakness, behavioral changes, seizures and coma
- Adrenergic-Sweating, palpitations, tremors and hyperphagia/obesity
- Improvement of symptoms after glucose infusion
- The diagnosis of insulinoma is based on the Biochemical assay with RadioImmunoAssay(RIA) and immunochemiluminescent assay(ICMA) in the abscence of plasma sulfonylureas (or drug causing hypoglycemia)[4][5]
- Insulin level >6uU/mL(43p mol/L by RIA and ≥3uU/ml by ICMA
- Glucose level <2.5mmol/L(45 mg/dL)
- C-peptide level ≥200 pmol/L
- Pronsulin level ≥25% or ≥22pmol/L is included in some criteria also
- The gold standard for diagnosis classically had been 72 hour fasting test[5][4]
- 33% patients develop symptoms in 12 hours, 80% at 24 hours, 90% after 48 hours and 100% after 72 hours of fasting.
Suspicion of Insulinoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Whipple's triad confirmed | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
72 hour fast | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Positive | Negative | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MRI/CT | Prolonged OGTT or mixed meal | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
No visible lesion | Visible lesion(s) | Unresectable liver metastasis | Nohypoglycemia | Hypoglycemia | |||||||||||||||||||||||||||||||||||||||||||||||||||||
F01 | F02 | F03 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
References
- ↑ Whipple AO, Frantz VK (1935). "ADENOMA OF ISLET CELLS WITH HYPERINSULINISM: A REVIEW". Ann. Surg. 101 (6): 1299–335. PMC 1390871. PMID 17856569.
- ↑ Metz DC, Jensen RT (2008). "Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors". Gastroenterology. 135 (5): 1469–92. doi:10.1053/j.gastro.2008.05.047. PMC 2612755. PMID 18703061.
- ↑ Boukhman MP, Karam JH, Shaver J, Siperstein AE, Duh QY, Clark OH (1998). "Insulinoma--experience from 1950 to 1995". West J Med. 169 (2): 98–104. PMC 1305178. PMID 9735690.
- ↑ 4.0 4.1 Metz, David C.; Jensen, Robert T. (2008). "Gastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors". Gastroenterology. 135 (5): 1469–1492. doi:10.1053/j.gastro.2008.05.047. ISSN 0016-5085.
- ↑ 5.0 5.1 Grant CS (2005). "Insulinoma". Best Pract Res Clin Gastroenterol. 19 (5): 783–98. doi:10.1016/j.bpg.2005.05.008. PMID 16253900.